Christian H. Lange - Jun 8, 2023 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Director
Signature
By: /s/ Matthew P. Blischak, Attorney-in-Fact
Stock symbol
FNCH
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:22 PM
Previous filing
Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FNCH Stock Option (right to buy) Award $0 +10K $0.00 10K Jun 8, 2023 Common Stock 10K $0.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in twelve equal monthly installments beginning on July 8, 2023, subject to the Reporting Person continuing to provide service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney